Insiders · NKTR

NKTR insider transactions

Nektar Therapeutics (NKTR) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for NKTR

• 13d
  SEC Form 3 filed by new insider Rubinstein Linda M

  3 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 18d
  Chief R&D Officer Zalevsky Jonathan sold $13,036 worth of shares (199 units at $65.51), decreasing direct ownership by 0.94% to 20,975 units (SEC Form 4) (withholding tax)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 18d
  President & CEO Robin Howard W sold $29,086 worth of shares (444 units at $65.51), decreasing direct ownership by 0.59% to 75,045 units (SEC Form 4) (tax withholding)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 108d
  Chief R&D Officer Zalevsky Jonathan sold $13,140 worth of shares (180 units at $73.00), decreasing direct ownership by 0.84% to 21,174 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 108d
  President & CEO Robin Howard W sold $30,879 worth of shares (423 units at $73.00), decreasing direct ownership by 0.56% to 75,489 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 137d
  Chief R&D Officer Zalevsky Jonathan sold $137,936 worth of shares (3,867 units at $35.67), decreasing direct ownership by 15% to 21,354 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 167d
  Chief R&D Officer Zalevsky Jonathan was granted 6,250 shares, increasing direct ownership by 33% to 25,221 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 167d
  President & CEO Robin Howard W was granted 21,667 shares, increasing direct ownership by 40% to 75,912 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 195d
  Chief R&D Officer Zalevsky Jonathan was granted 2,666 shares and sold $62,802 worth of shares (1,157 units at $54.28), increasing direct ownership by 9% to 18,971 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 195d
  Chief Legal Officer Wilson Mark Andrew sold $34,196 worth of shares (630 units at $54.28) and was granted 1,903 shares, increasing direct ownership by 6% to 21,585 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 195d
  President & CEO Robin Howard W was granted 7,110 shares and sold $119,796 worth of shares (2,207 units at $54.28), increasing direct ownership by 10% to 54,245 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 250d
  SEC Form 4 filed by Director Whitfield Roy A

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 250d
  SEC Form 4 filed by Director Greer R Scott

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 250d
  SEC Form 4 filed by Director Chess Robert

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 250d
  SEC Form 4 filed by Director Brainard Diana

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 250d
  SEC Form 4 filed by Director Ajer Jeffrey Robert

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 270d
  President & CEO Robin Howard W sold $311,214 worth of shares (6,666 units at $46.69), decreasing direct ownership by 12% to 49,342 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 273d
  Chief R&D Officer Zalevsky Jonathan sold $57,693 worth of shares (1,721 units at $33.52), decreasing direct ownership by 9% to 17,462 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 273d
  President & CEO Robin Howard W sold $430,959 worth of shares (11,832 units at $36.42), decreasing direct ownership by 17% to 56,008 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 277d
  Chief R&D Officer Zalevsky Jonathan sold $14,598 worth of shares (485 units at $30.10), decreasing direct ownership by 2% to 19,183 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 277d
  President & CEO Robin Howard W sold $45,240 worth of shares (1,500 units at $30.16), decreasing direct ownership by 2% to 67,840 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 291d
  Chief R&D Officer Zalevsky Jonathan sold $19,278 worth of shares (725 units at $26.59), decreasing direct ownership by 4% to 19,668 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 291d
  Chief Legal Officer Wilson Mark Andrew sold $17,975 worth of shares (676 units at $26.59), decreasing direct ownership by 3% to 20,312 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 291d
  President & CEO Robin Howard W sold $41,826 worth of shares (1,573 units at $26.59), decreasing direct ownership by 2% to 69,340 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 383d
  Chief R&D Officer Zalevsky Jonathan sold $7,177 worth of shares (10,712 units at $0.67), decreasing direct ownership by 3% to 305,892 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 383d
  Chief Legal Officer Wilson Mark Andrew sold $6,697 worth of shares (9,996 units at $0.67), decreasing direct ownership by 3% to 314,296 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 383d
  President & CEO Robin Howard W sold $15,549 worth of shares (23,208 units at $0.67), decreasing direct ownership by 2% to 1,063,693 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 472d
  Chief R&D Officer Zalevsky Jonathan sold $10,403 worth of shares (10,300 units at $1.01), decreasing direct ownership by 3% to 316,604 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 472d
  Chief Legal Officer Wilson Mark Andrew sold $11,150 worth of shares (11,040 units at $1.01), decreasing direct ownership by 3% to 324,292 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 472d
  President & CEO Robin Howard W sold $24,012 worth of shares (23,774 units at $1.01), decreasing direct ownership by 2% to 1,086,901 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 507d
  SEC Form 5 filed by Whitfield Roy A

  5 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 507d
  SEC Form 5 filed by Greer R Scott

  5 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 507d
  SEC Form 5 filed by Chess Robert

  5 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 507d
  SEC Form 5 filed by Brainard Diana

  5 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 507d
  SEC Form 5 filed by Ajer Jeffrey Robert

  5 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 529d
  Chief Legal Officer Wilson Mark Andrew sold $44,800 worth of shares (49,962 units at $0.90), decreasing direct ownership by 13% to 335,332 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 535d
  Chief R&D Officer Zalevsky Jonathan sold $48,048 worth of shares (51,115 units at $0.94), decreasing direct ownership by 14% to 326,904 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 536d
  President & CEO Robin Howard W sold $131,650 worth of shares (132,030 units at $1.00), decreasing direct ownership by 11% to 1,110,675 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 538d
  Chief R&D Officer Zalevsky Jonathan was granted 135,000 shares, increasing direct ownership by 56% to 378,019 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 538d
  Chief Legal Officer Wilson Mark Andrew was granted 165,938 shares, increasing direct ownership by 76% to 385,294 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 538d
  President & CEO Robin Howard W was granted 410,625 shares, increasing direct ownership by 49% to 1,242,705 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 565d
  Chief R&D Officer Zalevsky Jonathan sold $7,863 worth of shares (7,785 units at $1.01), decreasing direct ownership by 3% to 243,019 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 565d
  Chief Legal Officer Wilson Mark Andrew sold $6,471 worth of shares (6,407 units at $1.01), decreasing direct ownership by 3% to 218,856 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 565d
  President & CEO Robin Howard W sold $16,441 worth of shares (16,278 units at $1.01), decreasing direct ownership by 2% to 832,080 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 657d
  Chief R&D Officer Zalevsky Jonathan sold $8,788 worth of shares (6,866 units at $1.28), decreasing direct ownership by 3% to 250,804 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 657d
  Chief Legal Officer Wilson Mark Andrew sold $7,233 worth of shares (5,651 units at $1.28), decreasing direct ownership by 2% to 225,263 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 657d
  President & CEO Robin Howard W sold $19,048 worth of shares (14,881 units at $1.28), decreasing direct ownership by 2% to 848,358 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 724d
  Director Chess Robert sold $23,400 worth of shares (19,500 units at $1.20), decreasing direct ownership by 7% to 255,273 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 749d
  Robin Howard W sold $29,138 worth of shares (16,650 units at $1.75), decreasing direct ownership by 2% to 863,239 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 749d
  Zalevsky Jonathan sold $12,871 worth of shares (7,355 units at $1.75), decreasing direct ownership by 3% to 257,670 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 749d
  Wilson Mark Andrew sold $10,955 worth of shares (6,260 units at $1.75), decreasing direct ownership by 3% to 230,414 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 756d
  Deep Track Capital, Lp sold $99,630 worth of shares (56,000 units at $1.78) (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 816d
  New insider Deep Track Capital, Lp claimed ownership of 18,400,000 shares (SEC Form 3)

  3 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 837d
  Zalevsky Jonathan sold $6,130 worth of shares (9,014 units at $0.68), decreasing direct ownership by 3% to 265,025 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 837d
  Wilson Mark Andrew sold $5,172 worth of shares (7,606 units at $0.68), decreasing direct ownership by 3% to 236,674 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 837d
  Robin Howard W sold $13,622 worth of shares (20,033 units at $0.68), decreasing direct ownership by 2% to 879,889 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 906d
  SEC Form 4 filed by Zalevsky Jonathan

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 906d
  SEC Form 4 filed by Wilson Mark Andrew

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 906d
  SEC Form 4 filed by Robin Howard W

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)
• 931d
  Zalevsky Jonathan sold $4,727 worth of shares (9,646 units at $0.49), decreasing direct ownership by 3% to 274,039 units (SEC Form 4)

  4 - NEKTAR THERAPEUTICS (0000906709) (Issuer)